The drug manufacturer Merck wants to apply for emergency approval for an antiviral pill against Covid, the company announced.
A clinical study showed that the drug Molnupiravir reduced the risk of hospitalization or death by half when administered to patients at an early stage of their infection.
The study tracked 775 adults with mild-to-moderate Covid who were considered at higher risk for severe disease due to health problems such as obesity, diabetes ... Read even more
